home / stock / crvs / crvs short
Short Information | Corvus Pharmaceuticals Inc. (NASDAQ:CRVS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 848,989 |
Total Actual Volume | 3,985,811 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 0 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 42,449 |
Average Short Percentage | 23.50% |
Is there a CRVS Short Squeeze or Breakout about to happen?
See the CRVS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-18-2024 | $1.38 | $1.41 | $1.45 | $1.3 | 140,408 | 42,836 | 30.51% |
04-17-2024 | $1.5 | $1.36 | $1.5099 | $1.36 | 112,527 | 36,950 | 32.84% |
04-16-2024 | $1.44 | $1.47 | $1.51 | $1.36 | 91,660 | 24,185 | 26.39% |
04-15-2024 | $1.53 | $1.47 | $1.5364 | $1.41 | 69,358 | 6,994 | 10.08% |
04-12-2024 | $1.6 | $1.53 | $1.6205 | $1.5 | 155,480 | 25,722 | 16.54% |
04-11-2024 | $1.61 | $1.56 | $1.61 | $1.5201 | 122,961 | 44,502 | 36.19% |
04-10-2024 | $1.67 | $1.51 | $1.67 | $1.46 | 231,063 | 54,727 | 23.68% |
04-09-2024 | $1.71 | $1.63 | $1.78 | $1.6 | 196,127 | 72,946 | 37.19% |
04-08-2024 | $1.75 | $1.71 | $1.7899 | $1.68 | 120,413 | 35,206 | 29.24% |
04-05-2024 | $1.68 | $1.75 | $1.78 | $1.63 | 190,703 | 47,270 | 24.79% |
04-04-2024 | $1.77 | $1.69 | $1.85 | $1.685 | 211,179 | 38,542 | 18.25% |
04-03-2024 | $1.83 | $1.75 | $1.86 | $1.73 | 490,276 | 20,308 | 4.14% |
04-02-2024 | $1.83 | $1.86 | $1.9378 | $1.78 | 121,773 | 40,082 | 32.92% |
04-01-2024 | $1.78 | $1.86 | $1.89 | $1.74 | 117,250 | 25,975 | 22.15% |
03-28-2024 | $1.79 | $1.78 | $1.85 | $1.762 | 273,600 | 29,642 | 10.83% |
03-27-2024 | $1.77 | $1.79 | $1.85 | $1.76 | 161,298 | 37,173 | 23.05% |
03-26-2024 | $1.78 | $1.76 | $1.87 | $1.76 | 302,463 | 53,443 | 17.67% |
03-25-2024 | $1.8 | $1.76 | $1.835 | $1.72 | 277,924 | 87,391 | 31.44% |
03-22-2024 | $1.81 | $1.79 | $1.88 | $1.71 | 324,851 | 62,093 | 19.11% |
03-21-2024 | $1.92 | $1.84 | $1.95 | $1.79 | 274,497 | 63,002 | 22.95% |
News, Short Squeeze, Breakout and More Instantly...
Corvus Pharmaceuticals Inc. Company Name:
CRVS Stock Symbol:
NASDAQ Market:
Corvus Pharmaceuticals Inc. Website:
Atopic dermatitis is the first immune disease indication being studied in the clinic for soquelitinib, the Company’s selective ITK inhibitor Corvus anticipates releasing initial clinical data from trial before year-end 2024 BURLINGAME, Calif., April 09, 2024 (GLOBE NEWSWIRE...
Soquelitinib advancing towards initial enrollment for registrational Phase 3 clinical trial for PTCL and randomized Phase 1 clinical trial for atopic dermatitis Orphan drug designation and new interim data from Phase 1/1b clinical trial further demonstrate soquelitinib’s potentia...
BURLINGAME, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, ...